- Home
- CGC vs NBY Comparison
CGC vs NBY Comparison
Compare CGC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGC | NBY |
|---|---|---|
| Founded | N/A | 2000 |
| Country | Canada | United States |
| Employees | N/A | 14 |
| Industry | Pharmaceuticals and Biotechnology | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.3M | 31.6M |
| IPO Year | 2023 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CGC | NBY |
|---|---|---|
| Price | $1.02 | $1.21 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.5M | 817.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.75 | 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $12,759,000.00 | $370,000.00 |
| Revenue This Year | $8.04 | $23.91 |
| Revenue Next Year | $4.17 | $32.05 |
| P/E Ratio | ★ N/A | $1.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.77 | $0.43 |
| 52 Week High | $2.38 | $19.95 |
Technical Indicators
Market Signals| Indicator | CGC | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 38.48 | 41.39 |
| Support Level | $1.01 | $0.94 |
| Resistance Level | $1.24 | $1.36 |
| Average True Range (ATR) | 0.04 | 0.21 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 2.78 | 5.87 |
Price Performance
Historical ComparisonAbout CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.